Advanced Hr Breast Cancer clinical trials

Explore recruiting advanced hr breast cancer clinical trials.

Recruiting advanced hr breast cancer studies right now

Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Advanced Hr Breast Cancer trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A Phase Ib/II, Multicenter Study of the Combination of LEE011 and BYL719 With Letrozole in Adult Patients With Advanced ER+ Breast Cancer

France, Spain

Phase I and Phase II (Integrated)- Other EU CTIS Study details

Advanced Hr Breast Cancer trials by city

Advanced Hr Breast Cancer clinical trials

Recruiting advanced hr breast cancer studies right now

Open-Label Study of BBO-10203 in Subjects With Advanced Solid Tumors

A Study of Chidamide Plus Endocrine in Maintenance Treatment of HR+/HER2- Breast Cancer After First-line Chemotherapy

A Study to Learn About the Study Medicine Called PF-07248144 in Combination With Fulvestrant in People With HR-positive, HER2-negative Advanced or Metastatic Breast Cancer Who Progressed After a Prior Line of Treatment.

Phase 1/2 Study of ETX-636 in Participants With Advanced Solid Tumors

Study of AVZO-021 in Patients With Advanced Solid Tumors

A Study of BPI-1178 in Patients With Advanced Solid Tumor and HR+/HER2- Breast Cancer

Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)

PARP Inhibitor With CDK4/6 Inhibitor and Endocrine Therapy in HR+/ HER2-Advanced Breast Cancer

Study of MT-302 in Adults With Advanced or Metastatic Epithelial Tumors

Study of IEV407 as Single Agent or in Combination in Patients With Advanced HR+/HER2- Breast Cancer

Apatinib With CDK4/6 Inhibitor and Endocrine Therapy in HR+/ HER2- Advanced Breast Cancer

A Phase 2 Study to Evaluate the Efficacy, Safety and Pharmacokinetics of YL202 in Patients With BC

Also recruiting in Europe

A Phase Ib/II, Multicenter Study of the Combination of LEE011 and BYL719 With Letrozole in Adult Patients With Advanced ER+ Breast Cancer

Advanced Hr Breast Cancer trials by city

Other conditions